Ironwood Pharma
@ironwoodpharma.com
Explore Ironwood Pharmaceuticals' commitment to GI health with innovative therapies, patient-focused research, and a vision to improve digestive disease treatment.
Ironwood Pharma's Company Logos
Ironwood Pharma's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#99C13C
Sushi
153, 193, 60
78, 53, 50
21, 0, 69, 24
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#01B3DC
Cerulean
1, 179, 220
191, 99, 43
100, 19, 0, 14
About Ironwood Pharma
Ironwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company dedicated to advancing the treatment of GI diseases and redefining the standard of care for GI patients. With one in five Americans suffering from GI diseases, Ironwood's mission is crucial in providing relief and improving outcomes for millions of individuals. Each year, GI diseases result in millions of hospital visits and billions of dollars in healthcare costs.
With a singular focus on GI and a team of seasoned GI experts, Ironwood Pharmaceuticals has gained a deep understanding of the unique GI patient journey. This knowledge guides their approach to drug discovery and enables them to develop innovative solutions that address the specific needs of GI patients. Ironwood offers a diverse pipeline of therapeutic options and cutting-edge products aimed at improving the lives of those affected by GI conditions.
Their commitment to compassion and scientific excellence drives them to constantly push the boundaries of innovation in order to deliver value to patients. At Ironwood, employees are empowered to make a difference in the lives of those suffering from gastrointestinal diseases. The company fosters a culture of collaboration, innovation, and reward, encouraging employees to share best practices and challenge each other to reach new heights.
Ironwood Pharmaceuticals is at the forefront of advancing innovation in GI healthcare. With a focus on compassion, scientific expertise, and a dedication to improving patient outcomes, Ironwood is transforming the landscape of GI treatment
Company type
Public Company
Year founded
1998
Company size
201-500 employees
Related Brands
Tags
Gastrointestinal biopharmaceuticals
Prescription GI medicines
LINZESS linaclotide
Drug discovery for GI diseases
Clinical trials for SBS-IF
